Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children

Active, not recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

May 31, 2025

Study Completion Date

November 30, 2025

Conditions
Eosinophilic Esophagitis
Interventions
DRUG

Dose

The outcomes of reducing to half of the topical steroid (i.e. fluticasone \[Flovent\] and Swallowed viscous budesonide \[Pulmicort\]) will be observed with regards to whether the patients continue to be in histologic remission. These patients will have already achieved remission on a full dose of the steroid.

Trial Locations (1)

60611

Ann & Robert H Lurie Childjren's Hospital of Chicago, Chicago

All Listed Sponsors
lead

Ann & Robert H Lurie Children's Hospital of Chicago

OTHER

NCT05309590 - Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children | Biotech Hunter | Biotech Hunter